The survey also includes a question on respondents self-reported perception of their own weight that is used in CDC surveys
References Garvey W, Duque do Vale R, Karlsson T, et al
[11] Pisani D, Micallef D, Scerri J, et al
Tirzepatide for Weight Loss: What It Is and Who Its For Tirzepatide was approved by the FDA in 2022 for type 2 diabetes, and in 2023 for weight control for people with obesity or overweight and at least one weight-related condition (like high blood pressure or cholesterol)
To view or add a comment, sign in 74,365 followers More from this author When do we use an N95/P2 mask vs normal surgical mask
Comprender estas alternativas permite una toma de decisiones informada y personalizada